AVCN.TO
Avicanna Inc
Price:  
0.23 
CAD
Volume:  
157,910.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AVCN.TO EV/EBITDA

4.0%
Upside

As of 2025-04-21, the EV/EBITDA ratio of Avicanna Inc (AVCN.TO) is -6.40. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVCN.TO's latest enterprise value is 24.77 mil CAD. AVCN.TO's TTM EBITDA according to its financial statements is -3.87 mil CAD. Dividing these 2 quantities gives us the above AVCN.TO EV/EBITDA ratio.

Range Selected
Trailing P/E multiples - -
Forward P/E multiples 0.7x - 0.7x 0.7x
Fair Price 0.24 - 0.24 0.24
Upside 4.0% - 4.0% 4.0%
0.23 CAD
Stock Price
0.24 CAD
Fair Price

AVCN.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-04-17 -6.40
2025-04-16 -6.69
2025-04-15 -7.26
2025-04-14 -8.11
2025-04-11 -6.40
2025-04-10 -6.12
2025-04-09 -6.69
2025-04-08 -6.55
2025-04-07 -6.69
2025-04-04 -5.83
2025-04-03 -6.97
2025-04-02 -6.97
2025-04-01 -7.54
2025-03-31 -8.54
2025-03-28 -9.11
2025-03-27 -8.68
2025-03-26 -8.68
2025-03-25 -9.25
2025-03-24 -9.25
2025-03-21 -10.11
2025-03-20 -9.68
2025-03-19 -10.68
2025-03-18 -10.53
2025-03-17 -9.96
2025-03-14 -9.82
2025-03-13 -9.82
2025-03-12 -9.82
2025-03-11 -10.39
2025-03-10 -10.53
2025-03-07 -10.39
2025-03-06 -9.68
2025-03-05 -7.83
2025-03-04 -8.11
2025-03-03 -7.97
2025-02-28 -8.83
2025-02-27 -8.97
2025-02-26 -7.54
2025-02-25 -7.26
2025-02-24 -7.83
2025-02-21 -7.40
2025-02-20 -7.12
2025-02-19 -7.26
2025-02-18 -7.26
2025-02-14 -6.69
2025-02-13 -7.26
2025-02-12 -6.97
2025-02-11 -6.97
2025-02-10 -7.12
2025-02-07 -7.40
2025-02-06 -8.11